How do I distinguish major depressive disorder from depression secondary to chronic medical illness or an adjustment disorder in a 47‑year‑old married Caucasian male with obesity, hypertension, type 2 diabetes, hypothyroidism, chronic pulmonary disease from coccidioidomycosis, and pending triple‑bypass cardiac surgery, and what antidepressant selection and dosing considerations are most critical given his extensive comorbidities and upcoming surgery?

Distinguishing Major Depressive Disorder from Depression Secondary to Medical Illness or Adjustment Disorder

In this patient, the diagnosis is Major Depressive Disorder (MDD), not adjustment disorder or depression secondary to medical illness, because his symptoms meet full DSM-5-TR criteria with pervasive anhedonia, cognitive distortions (worthlessness, hopelessness), functional impairment lasting over 6 years, and severity (PHQ-9 = 17) that far exceeds what would be expected from normal adaptation to illness. 1

Diagnostic Differentiation Framework

Key Discriminating Features for MDD vs. Adjustment Disorder

Focus on affective and cognitive symptoms rather than somatic symptoms when medical comorbidity is present:

• Affective/cognitive symptoms (depressed mood, anhedonia, worthlessness, hopelessness, guilt, passive death wishes) are the most reliable discriminators in medically ill patients 2
• Somatic/vegetative symptoms (fatigue, sleep disturbance, appetite changes) overlap with medical illness and are less diagnostically useful unless they are severe, disproportionate to the medical condition, and temporally linked to mood symptoms 2

This patient demonstrates clear affective/cognitive predominance: persistent low mood for 6+ years, pervasive anhedonia across multiple previously enjoyed activities, feelings of worthlessness and being a burden, hopelessness, loss of self-esteem, and tearfulness—all meeting MDD criteria 1

MDD vs. Adjustment Disorder: Duration and Severity

Adjustment disorder should resolve within 6 months of stressor cessation or require only supportive interventions:

• Adjustment disorder patients typically receive higher Axis IV stress ratings, are seen later in hospital stay, show lower severity of illness, and are more likely to improve with supportive measures alone 3
• MDD patients are more likely to be older, widowed, living alone, and require pharmacologic or structured psychotherapeutic intervention 3

This patient's 6-year duration, moderate-to-severe symptoms (PHQ-9 = 17), failure to improve with time alone, and need for antidepressant medication all point definitively to MDD, not adjustment disorder 3, 1

Depression Secondary to Medical Condition vs. Primary MDD

Depression "secondary to" a medical condition (DSM-5-TR: Depressive Disorder Due to Another Medical Condition) requires direct pathophysiological causation:

• Examples include hypothyroidism causing depression through thyroid hormone deficiency, or stroke causing depression through direct brain injury 4
• Temporal relationship alone is insufficient—there must be a plausible biological mechanism by which the medical condition directly produces depressive symptoms 4

In this patient:

• His hypothyroidism is treated with levothyroxine, so thyroid dysfunction is not the cause 4
• Coccidioidomycosis and pulmonary disease do not have direct CNS pathophysiology causing depression 4
• The depression is better explained by psychological reaction to chronic illness, disability, and identity loss rather than direct biological causation 1, 4
• Therefore, this is primary MDD in the context of medical illness, not depression secondary to medical illness 1, 4

Common Pitfall: Delirium Must Be Excluded

Always rule out delirium before diagnosing depression in medically complex patients:

• Delirium presents with acute onset, fluctuating course, inattention, and altered consciousness—none of which this patient demonstrates 1
• This patient is alert, oriented, with linear thought process and no perceptual disturbances 1

---

Antidepressant Selection and Dosing in This Medically Complex Patient

Continue sertraline with cautious dose escalation to 75–100 mg daily, as it is already tolerated and SSRIs have the best safety profile in cardiac patients, while closely monitoring for drug interactions with voriconazole and perioperative risks around cardiac surgery. 5, 1

First-Line Antidepressant Choice: SSRI (Sertraline)

SSRIs are first-line for depression in cardiac patients:

• Sertraline and citalopram have the most evidence for safety in cardiovascular disease 5
• SSRIs have similar efficacy to other antidepressants but lower cardiac toxicity than tricyclics 5, 1
• This patient is already on sertraline 50 mg with partial response and good tolerability, so dose optimization is the logical next step 5

Gradual titration to 75–100 mg daily is appropriate:

• Use slow, cautious dose adjustments due to polypharmacy, cardiopulmonary disease, and upcoming surgery 1
• Monitor for serotonin syndrome, bleeding risk (especially perioperatively), QT prolongation, and blood pressure changes 1

Critical Drug-Drug Interaction: Voriconazole

Voriconazole is a potent CYP2C19 and CYP3A4 inhibitor, which can increase sertraline levels:

• Sertraline is metabolized by CYP2C19, CYP2C9, and CYP3A4 1
• Monitor closely for serotonergic side effects (tremor, agitation, GI upset, sexual dysfunction) when increasing sertraline dose 1
• Consider smaller dose increments (e.g., 25 mg increases rather than 50 mg) given this interaction 1

Perioperative Considerations for Cardiac Surgery

Continue antidepressants through the perioperative period:

• Abrupt discontinuation increases risk of withdrawal symptoms and depressive relapse 6
• SSRIs have antiplatelet effects, but the risk of perioperative bleeding must be weighed against the risk of stopping antidepressants 1
• Coordinate with cardiology and anesthesia regarding bleeding risk vs. psychiatric stability 6

Monitor for postoperative psychiatric complications:

• Postoperative delirium occurs in ~30% of cardiac surgery patients and is associated with worse long-term outcomes 6
• Depression and anxiety disorders commonly worsen or emerge after cardiac surgery with cardiopulmonary bypass 6
• Cognitive deficits occur in a subset of patients and can impair quality of life at 1 year 6
• Close psychiatric follow-up during the perioperative period is essential 6

Second-Line Option: Bupropion XL (If Sertraline Inadequate)

Bupropion XL 150 mg daily may address anhedonia, low energy, and motivation if sertraline response remains inadequate:

• Bupropion has dopaminergic and noradrenergic effects that may improve motivational symptoms 5
• Requires cardiology clearance due to this patient's hypertension (BP 148/92) and pending cardiac surgery 1
• Bupropion can increase blood pressure and heart rate, so it must be used cautiously in cardiovascular disease 1
• Avoid in patients with seizure risk, but this patient has no such history 1

Medications to Avoid

Tricyclic antidepressants (TCAs) and MAOIs are contraindicated:

• TCAs have cardiotoxic effects (QT prolongation, arrhythmias, orthostatic hypotension) and are dangerous in cardiac patients 1
• MAOIs require dietary restrictions and have hypertensive crisis risk 1

Benzodiazepines should be avoided:

• Increase perioperative delirium risk and have cognitive side effects 6
• Prazosin 5 mg at bedtime is already being used for sleep and is safer than benzodiazepines 1

Adjunctive Considerations: GLP-1 Agonists for Weight Loss

The patient is considering GLP-1 agonists (e.g., semaglutide) for weight loss (BMI 32.3):

• Semaglutide 2.4 mg weekly improved quality of life, 6-minute walk distance, and depressive symptoms in obese patients with heart failure in the STEP-HFpEF trials 7
• GLP-1 agonists may have direct mood benefits in addition to metabolic improvements 8
• Coordinate with cardiology regarding timing relative to cardiac surgery 7
• This is a reasonable adjunctive strategy for this patient's obesity, diabetes, and cardiovascular disease 9, 7

Monitoring and Follow-Up

Schedule psychiatric follow-up in 4–6 weeks:

• Reassess depressive symptoms, suicidal ideation, medication tolerability, and drug interactions 1
• Monitor blood pressure, heart rate, and bleeding risk given cardiovascular comorbidities and upcoming surgery 1
• Coordinate with cardiology, pulmonology, and primary care to align psychiatric and medical management 5, 1

Integrate psychotherapy as a core component:

• Cognitive behavioral therapy (CBT) or acceptance and commitment therapy (ACT) should be initiated to address identity loss, worthlessness, and adaptation to chronic illness 5, 1
• Psychotherapy has small to moderate effect sizes and is essential for long-term recovery in medically ill patients 1
• Behavioral activation with gradual, medically appropriate activities (5–10 minutes daily) should be emphasized 1